{"id":"adicillin","rwe":[],"tags":[{"label":"adicillin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":["NCT06811207","NCT05469685","NCT05833854","NCT05934227","NCT05106803","NCT07068607","NCT05874544","NCT06929962","NCT02934152","NCT06250634","NCT06299605","NCT04986254","NCT05649540","NCT05846399","NCT03211156","NCT06162949","NCT07484633","NCT05658055","NCT06959368","NCT05726734","NCT05728424","NCT05419674","NCT06156085","NCT03376529","NCT01769027","NCT06101420","NCT02827942","NCT04352062","NCT06576882","NCT04775953","NCT01505127","NCT04907747","NCT00066066","NCT05957432","NCT05191888","NCT03637660","NCT07275827","NCT05189444","NCT06731023","NCT05014334","NCT04198363","NCT02969928","NCT07407673","NCT06349486","NCT07242456","NCT05620589","NCT06414707","NCT06561698","NCT06514274","NCT06168084"],"aliases":[],"patents":[],"pricing":[],"allNames":"penicillin n","offLabel":[],"synonyms":["Cephalosporin N","adicillin","adicillinum","Penicillin N","salmotin","Synnematin B"],"timeline":[],"brandName":"Penicillin N","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"adicillin","explanation":"Imagine the bacterial cell wall as a strong, protective shield. Penicillin N blocks the enzymes that help build this shield, causing the bacterial cell to weaken and eventually die. This allows the body's immune system to fight off the infection more effectively.","oneSentence":"Penicillin N works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to bacterial cell death.","technicalDetail":"Penicillin N exerts its antibacterial effects by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, inhibiting the transpeptidation reaction that cross-links peptidoglycan chains, and ultimately leading to cell lysis and death."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3421","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ADICILLIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:28:38.246081","biosimilars":[],"competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"adicillin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06811207","phase":"Phase 3","title":"Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","isPivotal":true,"enrollment":300,"indication":"HELICOBACTER PYLORI INFECTIONS","completionDate":"2025-02-28"},{"nctId":"NCT05469685","phase":"Phase 4","title":"Efficacy and Safety of Vonoprazan- Amoxicillin Dual Therapy for Helicobacter Pylori Eradication : a Prospective, Multicenter, Randomized Controlled Trial","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","isPivotal":false,"enrollment":914,"indication":"Helicobacter Pylori Infection","completionDate":"2023-09-30"},{"nctId":"NCT05833854","phase":"NA","title":"The Effect of Use of Virtual Reality Glasses and Manual Pressure Method on the Level of Pain and Fear in Children During Intramuscular Injection","status":"COMPLETED","sponsor":"Selmin Kose","isPivotal":false,"enrollment":75,"indication":"Intramuscular Injection","completionDate":"2024-02-29"},{"nctId":"NCT05934227","phase":"NA","title":"Long-term Effects of Sub Gingival Debridement Associated With Antibiotics in Individual Undergoing Maintenance Periodontal Therapy","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","isPivotal":false,"enrollment":50,"indication":"Periodontitis, Periodontal Pocket","completionDate":"2024-09-01"},{"nctId":"NCT05106803","phase":"N/A","title":"Antibiotic Profile of Pathogenic Bacteria Isolated From Postsurgical Site Infections in Public Hospitals in Northern Jordan","status":"COMPLETED","sponsor":"Yarmouk University","isPivotal":false,"enrollment":24,"indication":"Bacterial Infections, Antibiotic Resistant Infection","completionDate":"2019-10-01"},{"nctId":"NCT07068607","phase":"Phase 4","title":"Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial","status":"RECRUITING","sponsor":"Yongquan Shi","isPivotal":false,"enrollment":400,"indication":"Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer","completionDate":"2025-11-01"},{"nctId":"NCT05874544","phase":"Phase 4","title":"Rifabutin-containing Triple Therapy for Helicobacter Pylori Rescue Treatment: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","isPivotal":false,"enrollment":360,"indication":"Helicobacter Pylori Infection","completionDate":"2025-01-31"},{"nctId":"NCT06929962","phase":"Phase 4","title":"Vonoprazan-Amoxicillin Dual Sequential Therapy For Helicobacter Pylori-infected Treatment-naive Patients：A Randomized, Open-label, Parallel-controlled , Multicenter Clinical Trial","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","isPivotal":false,"enrollment":600,"indication":"Helicobacter Pylori Infection","completionDate":"2026-12-31"},{"nctId":"NCT02934152","phase":"Phase 4","title":"Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","isPivotal":false,"enrollment":400,"indication":"Gastroesophageal Reflux Disease","completionDate":"2019-09"},{"nctId":"NCT06250634","phase":"NA","title":"Esomeprazole / Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection: a Multi-center, Prospective, Open-label, Randomized Controlled Clin","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","isPivotal":false,"enrollment":806,"indication":"Helicobacter Pylori Infection","completionDate":"2024-05-10"},{"nctId":"NCT06299605","phase":"NA","title":"Triple Versus Quadruple Therapy with Amoxicillin and Tetracycline for the Eradication of Helicobacter Pylori: a Multicenter Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Shandong University","isPivotal":false,"enrollment":375,"indication":"Helicobacter Pylori Infection","completionDate":"2025-11-30"},{"nctId":"NCT04986254","phase":"N/A","title":"A Multi-centre Study to Define Novel Individualised Dosing Regimens to Maximise Antibiotic Effectiveness for Treatment of Pneumonia in Intensive Care Units","status":"COMPLETED","sponsor":"The University of Queensland","isPivotal":false,"enrollment":179,"indication":"Pneumonia","completionDate":"2024-01-31"},{"nctId":"NCT05649540","phase":"Phase 4","title":"Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori:a Prospective, Multicenter, Open Label, Randomized Controlled Study:","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","isPivotal":false,"enrollment":900,"indication":"Helicobacter Pylori Infection","completionDate":"2024-11-05"},{"nctId":"NCT05846399","phase":"Phase 4","title":"CAT BITE Antibiotic Prophylaxis and Durations for the Hand/Forearm (CATBITE): A Prospective, Randomized, Placebo-controlled, Double-blinded, Clinical Trial","status":"RECRUITING","sponsor":"University of Missouri-Columbia","isPivotal":false,"enrollment":72,"indication":"Cat Bite, Hand Injuries","completionDate":"2027-08-01"},{"nctId":"NCT03211156","phase":"Phase 2","title":"A Randomized, Double-Blind, Placebo Controlled, Phase 2 Study to Assess Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":97,"indication":"Vaginitis Gardnerella","completionDate":"2019-08-22"},{"nctId":"NCT06162949","phase":"Phase 3","title":"Vonoprazan-based Triple Therapy vs. Standard Triple Therapy for Helicobacter Pylori Eradication in Adolescents: A Randomized, Double-blinded Controlled Trial","status":"COMPLETED","sponsor":"Alexandria University","isPivotal":true,"enrollment":242,"indication":"Treatment Effectiveness","completionDate":"2024-08-01"},{"nctId":"NCT07484633","phase":"Phase 4","title":"A Protocol of a Randomised, Two-arm Superiority Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients","status":"NOT_YET_RECRUITING","sponsor":"Semmelweis University","isPivotal":false,"enrollment":110,"indication":"Infection, Sepsis","completionDate":"2028-04"},{"nctId":"NCT05658055","phase":"Phase 4","title":"The Effect of Probiotics With Vonoprazan-amoxicillin Dual Therapy on Gut Microbiotain After Helicobacter Pylori Eradication: A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","isPivotal":false,"enrollment":100,"indication":"Helicobacter Pylori Infection, Infections","completionDate":"2023-12-31"},{"nctId":"NCT06959368","phase":"Phase 4","title":"A Randomised Controlled Trial Comparing Vonoprazan Triple Therapy (Vonoprazan, Amoxicillin, Clarithromycin), and Standard Triple Therapy (Esomeprazole, Amoxicillin, Clarithromycin) for Helicobacter Py","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","isPivotal":false,"enrollment":484,"indication":"Helicobacter Pylori Infection","completionDate":"2026-03-25"},{"nctId":"NCT05726734","phase":"Phase 4","title":"Efficacy of Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","isPivotal":false,"enrollment":100,"indication":"Helicobacter Pylori Infection","completionDate":"2026-02-06"},{"nctId":"NCT05728424","phase":"Phase 3","title":"ONE WEEK VS. TWO WEEKS VONOPRAZAN CONTAINING TRIPLE REGIMEN FOR ERADICATION OF HELICOBACTER PYLORI:","status":"UNKNOWN","sponsor":"Aga Khan University","isPivotal":true,"enrollment":246,"indication":"Helicobacter Pylori Infection","completionDate":"2023-05-01"},{"nctId":"NCT05419674","phase":"Phase 4","title":"Ten-day Amoxicillin-containing Dual Therapy as First-line Helicobacter Pylori Treatment in Elderly Patients: a Randomized Trial","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","isPivotal":false,"enrollment":393,"indication":"Helicobacter Pylori Infection","completionDate":"2023-08-01"},{"nctId":"NCT06156085","phase":"Phase 4","title":"Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled Trial in Taiwan","status":"COMPLETED","sponsor":"Fu Jen Catholic University Hospital","isPivotal":false,"enrollment":337,"indication":"Helicobacter Pylori Infection","completionDate":"2024-12-03"},{"nctId":"NCT03376529","phase":"Phase 1","title":"A Single-center, Multi-arm, Open-label, Randomized, 3-period, Crossover, Phase 1 Study to Evaluate the DDI, PK, Safety, and Tolerability of Single Doses of SPR741 Co-administered With Three Different ","status":"COMPLETED","sponsor":"Spero Therapeutics","isPivotal":false,"enrollment":27,"indication":"Healthy Volunteers","completionDate":"2017-12-20"},{"nctId":"NCT01769027","phase":"Phase 2","title":"Antibiotic Treatment and Intravenous Immunoglobulin Double-blind, Randomized, Placebo-controlled Trial for PANDAS","status":"WITHDRAWN","sponsor":"CNS Onlus","isPivotal":false,"enrollment":0,"indication":"Pandas","completionDate":"2016-06"},{"nctId":"NCT06101420","phase":"Phase 3","title":"Efficacy of Potassium Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the First and the Second Lines Eradication Regimens for H. Pylori in Egyptian Patients","status":"COMPLETED","sponsor":"Ain Shams University","isPivotal":true,"enrollment":232,"indication":"Helicobacter Pylori Eradication","completionDate":"2023-06-01"},{"nctId":"NCT02827942","phase":"Phase 3","title":"Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Hamamatsu University","isPivotal":true,"enrollment":112,"indication":"Gastritis Associated With Helicobacter Pylori","completionDate":"2019-03-31"},{"nctId":"NCT04352062","phase":"NA","title":"The Usefulness of Melatonin Supplementation in Postmenopausal Women With Helicobacter Pylori-associated Dyspepsia","status":"COMPLETED","sponsor":"Medical University of Lodz","isPivotal":false,"enrollment":152,"indication":"Melatonin Deficiency","completionDate":"2018-10-26"},{"nctId":"NCT06576882","phase":"Phase 3","title":"7-day Versus 14-day Vonoprazan-based Triple Therapy for Eradication of H. Pylori in Adolescents: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Alexandria University","isPivotal":true,"enrollment":326,"indication":"Helicobacter Pylori Infection, Gastritis","completionDate":"2024-12-01"},{"nctId":"NCT04775953","phase":"Phase 2","title":"Dalbavancin as an Option for Treatment of S. Aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbava","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":200,"indication":"Staphylococcal Bacteraemia","completionDate":"2023-12-01"},{"nctId":"NCT01505127","phase":"Phase 3","title":"A Phase 3, Randomized, Double-Blind, Double Dummy, Multicenter, Parallel Group Comparison Study to Evaluate Efficacy and Safety of a Triple Therapy With TAK-438, Amoxicillin and Clarithromycin by Comp","status":"COMPLETED","sponsor":"Takeda","isPivotal":true,"enrollment":650,"indication":"H. Pylori Infection","completionDate":"2013-06"},{"nctId":"NCT04907747","phase":"Phase 4","title":"Efficacy and Safety of Furazolidone-based Quadruple Therapy With Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication: A Prospective Randomized Trial","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","isPivotal":false,"enrollment":234,"indication":"Helicobacter Pylori Infection","completionDate":"2022-04-13"},{"nctId":"NCT00066066","phase":"Phase 2","title":"Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers","status":"COMPLETED","sponsor":"The Forsyth Institute","isPivotal":false,"enrollment":146,"indication":"Periodontitis, Periodontal Diseases","completionDate":"2009-07"},{"nctId":"NCT05957432","phase":"Phase 2","title":"Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","isPivotal":false,"enrollment":90,"indication":"Helicobacter Pylori Infection","completionDate":"2025-11"},{"nctId":"NCT05191888","phase":"Phase 4","title":"14-day PCAB-based and Reverse Hybrid Therapy Fro Helicobacter Pylori","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","isPivotal":false,"enrollment":906,"indication":"Helicobacter Pylori Eradication","completionDate":"2024-12-31"},{"nctId":"NCT03637660","phase":"Phase 4","title":"A Phase 4 Comparative Trial of Benzathine Penicillin G 2.4 Million Units Administered as a Single Dose Versus Three Successive Weekly Doses for Treatment of Early Syphilis in Subjects With or Without ","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":249,"indication":"Syphilis","completionDate":"2023-03-20"},{"nctId":"NCT07275827","phase":"Phase 3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","isPivotal":true,"enrollment":88,"indication":"HELICOBACTER PYLORI INFECTIONS","completionDate":"2026-10"},{"nctId":"NCT05189444","phase":"NA","title":"The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori: a Prospective, Multi-Center, Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","isPivotal":false,"enrollment":672,"indication":"Helicobacter Pylori Infection","completionDate":"2022-12-31"},{"nctId":"NCT06731023","phase":"N/A","title":"Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study","status":"NOT_YET_RECRUITING","sponsor":"Xiuli Zuo","isPivotal":false,"enrollment":30,"indication":"HELICOBACTER PYLORI INFECTIONS","completionDate":"2026-12-31"},{"nctId":"NCT05014334","phase":"Phase 4","title":"Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","isPivotal":false,"enrollment":300,"indication":"Helicobacter Pylori Infection, Chronic Gastritis","completionDate":"2022-06-30"},{"nctId":"NCT04198363","phase":"Phase 3","title":"A Randomized Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral TAK-438 20 mg Compared to Esomeprazole 20 mg Twice Daily in Subjects With","status":"COMPLETED","sponsor":"Takeda","isPivotal":true,"enrollment":510,"indication":"Helicobacter Pylori","completionDate":"2021-11-25"},{"nctId":"NCT02969928","phase":"Phase 2","title":"Full-mouth Periodontal Debridement Associated With Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","isPivotal":true,"enrollment":46,"indication":"Aggressive Periodontitis","completionDate":"2016-12"},{"nctId":"NCT07407673","phase":"Phase 2","title":"Prediction and Prevention of Bloodstream Infections After Kidney Transplantation - The PREDICT Study","status":"NOT_YET_RECRUITING","sponsor":"Susanne Dam Nielsen, MD, DMSc","isPivotal":false,"enrollment":150,"indication":"Kidney Transplant Infection, Bloodstream Infection","completionDate":"2029-07"},{"nctId":"NCT06349486","phase":"NA","title":"Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy in the First-line Anti-H. Pylori Treatment","status":"RECRUITING","sponsor":"Kaohsiung Medical University","isPivotal":false,"enrollment":390,"indication":"Helicobacter Pylori Eradication","completionDate":"2026-12-31"},{"nctId":"NCT07242456","phase":"Phase 2","title":"Head-to-head Comparison of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID Versus Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for Helicobacter Pylori Eradication: A Randomized, Open-label, Parallel-gr","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","isPivotal":true,"enrollment":240,"indication":"Helicobacter Pylori Infection","completionDate":"2026-01-31"},{"nctId":"NCT05620589","phase":"N/A","title":"The Effect of Different Time Intervals on Rescue Treatment of Helicobacter Pylori Infection: a Prospective, Multicenter Observational Study","status":"UNKNOWN","sponsor":"Shandong University","isPivotal":false,"enrollment":626,"indication":"Helicobacter Pylori Infection","completionDate":"2024-12-31"},{"nctId":"NCT06414707","phase":"Phase 3","title":"Efficacy of Vonoprazan Versus Proton Pump Inhibitors in Combination With Antibiotics as a Triple Therapy for Eradication of Clarithromycin Resistant Strain of Helicobacter Pylori","status":"COMPLETED","sponsor":"Ain Shams University","isPivotal":true,"enrollment":320,"indication":"Helicobacter Pylori Infection","completionDate":"2024-04-04"},{"nctId":"NCT06561698","phase":"Phase 4","title":"High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","isPivotal":false,"enrollment":200,"indication":"Helicobacter Pylori Infection","completionDate":"2026-08-30"},{"nctId":"NCT06514274","phase":"Phase 4","title":"Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","isPivotal":false,"enrollment":558,"indication":"Helicobacter Pylori Infection, Chronic Gastritis","completionDate":"2025-06-25"},{"nctId":"NCT06168084","phase":"Phase 4","title":"Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","isPivotal":false,"enrollment":688,"indication":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","completionDate":"2024-08-30"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"NOF9U9EYQ4","CHEBI":"CHEBI:18203","INN_ID":"1647","UMLSCUI":"C0070233","ChEMBL_ID":"CHEMBL2023705","PUBCHEM_CID":"71724","MESH_SUPPLEMENTAL_RECORD_UI":"C006414"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Penicillin N, also known as Adicillin, is a small molecule antibiotic in the adicillin class. Its mechanism of action involves inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. However, due to the lack of available information, its target, FDA approval status, and commercial status are unknown. Adicillin is used to treat various bacterial infections, but the specific indications are not specified. Further research is needed to fully understand its pharmacokinetic properties and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}